BIOTECH
BIOTECH
Lattice Medical raises €43 million to transform post-cancer reconstruction
Lille, France, October 23, 2025 – LATTICE MEDICAL, a French Medtech company specializing in tissue...
Read moreBIOTECH
TREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal Cancer
LONDON, Aug. 27, 2025 (GLOBE NEWSWIRE) — TREOS Bio Ltd., a clinical-stage biotechnology company developing...
Read moreBIOTECH
Vaxxas secures ~A$90 million in funding to commercialise needle-free vaccination delivery technology
BRISBANE, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Vaxxas Pty Ltd, the biotechnology company pioneering...
Read moreBIOTECH
Doron Therapeutics Announces Positive End-of-Phase 2 and Initial RMAT Meeting With FDA for MOTYS (PTP-001) in the Treatment of Knee Osteoarthritis
CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / May 20, 2025 / Doron Therapeutics, a clinical-stage biotechnology company...
Read moreBIOTECH
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform
GHENT, Belgium–(BUSINESS WIRE)–Azalea (A-zuh-lay-ah) Vision, a HealthTech company engineering the future of sight, today announced the...
Read more